Zubrin is a registered trademark of Schering-Plough Animal Health Corporation. Copyright 2006 Schering-Plough Animal Health Corporation. All rights reserved. Please see our privacy policy and product information. As a class, cyclooxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal, and hepatic side effects. These side effects are generally mild, but can be serious. Pet owners should be advised to observe for signs of potential drug toxicity. Dogs should be evaluated before beginning treatment, and regularly monitored throughout therapy. For side effects and warnings, please see accompanying full product Information. The relationship between Cox/Lox inhibition and safety and efficacy of Zubrin¨ in dogs has not been established.